Glaxo SmithKline
- 31.00 EGP
- 0.11
- 0.36%
Glaxo SmithKline Stock Overview
View Company ProfileStock Summary
| Last Price (EGP) | 31.00 |
| Prev. Close | 30.890 |
| Day Range | 29.19 - 31.88 |
| 52WK range | |
| Turnover (M EGP) | 0.82 |
| Volume (M) | 0.03 |
| Number of Trades | 118 |
| Market Cap (M EGP) | 3,102.55 |
| Change in Market Cap (M EGP) | |
| VWAP (EGP) | 30.78 |
| EPS (TTM) | -- |
| EX-Dividend Date | |
| Dividend | |
| Dividend Yield (%) | |
| Beta | |
| 30D Avg Volume | |
| 30D Avg Turnover(M EGP) | |
| Outstanding Shares | |
| Free Float Shares | |
| Free Float % |
Stock Performance
Stock Highlights
| Highest Market Cap | |
| Date of Highest Mkt. Cap | |
| Lowest Market Cap | |
| Date of Lowest Mkt. Cap |
Earnings Progress
News
More Company News
GSK Egypt’s consolidated profits plunge to EGP 60m...
Cairo – Mubasher: GlaxoSmithKline’s (GSK Egypt) consolidated net profit plunged to EGP 60.47 million in 2023 from EGP 735.39 million a...
GSK Egypt records plunge in 9M-23 profits; sales hit...
Cairo – Mubasher: The consolidated net profits after tax of GlaxoSmithKline (GSK Egypt) plummeted to EGP 46.72 million in the first nine...
GSK Egypt’s net profits shrink in H1-23 results
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) achieved consolidated net profits worth EGP 19.57 million in the first half (H1) of 2023,...
GSK Egypt generates lower consolidated profits in Q1-23
Cairo – Mubasher: The consolidated net profits after tax of GlaxoSmithKline (GSK Egypt) plummeted to EGP 13.81 million in the first quarter (Q1)...
GSK Egypt’s shareholders approve 2022 cash dividends
Cairo – Mubasher: The shareholders of GlaxoSmithKline (GSK Egypt) greenlighted a cash dividend distribution valued at EGP 0.75 per share for 2022.The...
